Spiracur® Inc., developer of a small, non-powered innovative negative pressure wound therapy (NPWT) device, today announced that it has been awarded a three-year new technology product supplier agreement by Novation, LLC (Irving, TX), the healthcare industry’s leading supply contracting company.
News & Events
Spiracur Announces First European Study Evaluating Outcomes for Treatment of Lower Extremity Diabetic, Venous and Mixed Etiology Wounds
November 15, 2011 – Spiracur® Inc., developer of an ultraportable and disposable negative pressure wound therapy (NPWT) device, announced today that a prospective study to evaluate outcomes for the treatment of lower extremity diabetic, venous and mixed etiology leg wounds using the SNaP® Wound Care System is underway at Cardiff University School of Medicine in Wales.
Spiracur Introduces SNaP® BLUE Foam Dressing Kit
Nov. 2, 2011 – Spiracur Inc., developer of the SNaP® Wound Care System, an ultraportable and disposable negative pressure wound therapy (NPWT) device, today announced that it introduced its SNaP® BLUE Foam Dressing Kit at the Symposium on Advanced Wound Care (SAWC) Fall 2011
Spiracur Donates 25 SNaP® Wound Care Systems for UCSF IGOT Use and Training in Tanzania
October 5, 2011 – Spiracur Inc., developer of an ultraportable and disposable negative pressure wound therapy (NPWT) device, announced the donation of 25 SNaP® Wound Care Systems for teaching and use in Tanzania
Multicenter RCT Abstract Highlighting Spiracur’s SNaP® System Wins Highest Scoring Award at Symposium for Advanced Wound Care
Oct. 4, 2011 – The Symposium on Advanced Wound Care (SAWC) has awarded David G. Armstrong, DPM, M.D., Ph.D., et al., the highest scoring abstract in the clinical research category for their poster
Independence Blue Cross To Cover Spiracur’s SNaP® Wound Care System
July 14, 2011 – Spiracur Inc. announced today that Independence Blue Cross (IBC) of Pennsylvania has expanded its coverage policy to include Spiracur’s SNaP® Wound Care System, effective July 6, 2011.
Health Canada Issues Medical Device License to Spiracur, Inc. For SNaP® Wound Care System
July 12, 2011 – Spiracur Inc. received a medical device license from Health Canada permitting the company to sell its SNaP® Wound Care System (Smart Negative Pressure) throughout the country. Spiracur’s SNaP® System is a clinically proven, non-powered device designed to treat patients suffering from chronic
Leading Health Insurer, Highmark, Inc. to Cover Spiracur’s SNaP® Wound Care System
April 12, 2011 – Spiracur® Inc., the developer of an ultraportable and disposable negative pressure wound therapy (NPWT) device, and Highmark Inc., one of Pennsylvania’s leading health insurers, today announced new coverage for the SNaP® Wound Care System and related supplies.
Spiracur’s SNaP® Wound Care System Awarded American Podiatric Medical Association’s Seal of Approval
March 09, 2011 – Spiracur® Inc., the developer of an ultraportable and disposable negative pressure wound therapy (NPWT) device, today announced that it has been awarded the prestigious American Podiatric Medical Association’s (APMA) Seal of Approval for its innovative SNaP® Wound Care System. APMA, the leading resource for foot and ankle health information, awarded the Seal to Spiracur’s SNaP® System for its contributions to better foot health and mobility.
Interim Analysis Supports Efficacy and Safety of Spiracur’s Mechanically Powered SNaP® Wound Care System
March 08, 2011 – Spiracur Inc., the developer of an ultraportable and disposable negative pressure wound therapy (NPWT) device, today announced encouraging interim results from a clinical study highlighting the safety and efficacy of its SNaP® Wound Care System for the treatment of chronic lower extremity wounds. The study was published in the March-April 2011 issue of Wound Repair and Regeneration, the official peer-reviewed journal of the Wound Healing Society.